Ettore De Berardinis | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Systematic review and meta-analysis of serum total testosterone and luteinizing hormone variations across hospitalized Covid-19 patients	SCIENTIFIC REPORTS	2024
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐less’ Randomised Trial Protocol	BJU INTERNATIONAL	2024
Blood Extracellular Vesicles beyond Circulating Tumour Cells: A Valuable Risk Stratification Biomarker in High-Risk Non-Muscle-Invasive Bladder Cancer Patients	BIOMEDICINES	2024
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer	ONCOLOGY RESEARCH	2024
Seeing is believing: state of the art Imaging of bladder cancer	SEMINARS IN RADIATION ONCOLOGY	2023
Translation and validation of the Italian version of the Wisconsin Stone Quality of Life Questionnaire (I-WISQOL) for assessing quality of life in patients with urolithiasis	MINERVA UROLOGY AND NEPHROLOGY	2023
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: A meta-analysis and systematic review	ASIAN JOURNAL OF UROLOGY	2023
Mid-term outcomes of minimally invasive infrapubic approach for inflatable penile prosthesis implantation: A single-center study and literature review	ANDROLOGY	2023
Translation and validation of the Italian version of the Wisconsin Stone Quality of Life Questionnaire (I-WISQOL) for assessing quality of life in patients with urolithiasis	MINERVA UROLOGY AND NEPHROLOGY	2023
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?	WORLD JOURNAL OF UROLOGY	2023
Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence	JOURNAL OF PERSONALIZED MEDICINE	2023
A prospective observational study on oral administration of Ellagic Acid and Annona Muricata in patients affected by non-muscle invasive bladder cancer not undergoing maintenance after 6-week intravesical prophylaxis	UROLOGIA	2022
Contemporary trends of systemic neoadjuvant and adjuvant intravesical chemotherapy in patients with upper tract urothelial carcinomas undergoing minimally invasive or open radical nephroureterectomy: analysis of US claims on perioperative outcomes and health care costs	CLINICAL GENITOURINARY CANCER	2022
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis	CANCERS	2022
The association of impaired semen quality and pregnancy rates in assisted reproduction technology cycles: Systematic review and meta-analysis	ANDROLOGIA	2022
Which factors can influence post-operative renal function preservation after nephron-sparing surgery for kidney cancer: a critical review	CENTRAL EUROPEAN JOURNAL OF UROLOGY	2022
The accuracy of vesical imaging-reporting and data system (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations	WORLD JOURNAL OF UROLOGY	2022
Comparison of Different Invasive Devices for the Treatment of Urinary Incontinence after Radical Prostatectomy	ADVANCES IN UROLOGY	2022
Comment on: Postoperative outcomes of Fast-Track-enhanced recovery protocol in open radical cystectomy: comparison with standard management in a high-volume center and Trifecta proposal	MINERVA UROLOGY AND NEPHROLOGY	2022
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry	FRONTIERS IN ONCOLOGY	2022

Progetti di Ricerca

Interplay between intravesical Bacillus Calmette-Guerin and programmed death ligand 1 (PD-L1) expression in non- muscle invasive bladder cancer: an hypothesis generating study for intermittent immunotherapies
Oncogenic aberrations in tumor samples from transurethral resection of the bladder as predictive biomarkers of Bacillus Calmette-Guérin efficacy in non-muscle invasive bladder cancer patients.